|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,889.00 JPY | -0.13% |
|
-2.63% | -4.37% |
| 05-11 | Jefferies Adjusts Chugai Pharmaceutical's Price Target to 8,500 Yen from 9,100 Yen, Keeps at Hold | MT |
| 05-07 | Japan's Nikkei blazes past 63,000 on earnings, Iran peace optimism; JGBs rally | RE |
| Capitalization | 13,000B 81.86B 70.39B 64.44B 60.88B 113B 7,906B 114B 764B 299B 3,732B 307B 301B | P/E ratio 2026 * |
25.5x | P/E ratio 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise value | 12,030B 75.75B 65.14B 59.63B 56.34B 104B 7,316B 106B 707B 277B 3,454B 284B 278B | EV / Sales 2026 * |
8.7x | EV / Sales 2027 * | 7.74x |
| Free-Float |
38.12% | Yield 2026 * |
1.73% | Yield 2027 * | 1.95% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -0.20% | ||
| 1 week | -2.63% | ||
| Current month | -2.87% | ||
| 1 month | -9.33% | ||
| 3 months | -21.95% | ||
| 6 months | -5.80% | ||
| Current year | -4.37% |
| 1 week | 7,787 | 8,151 | |
| 1 month | 7,402 | 9,013 | |
| Current year | 7,402 | 10,700 | |
| 1 year | 5,942 | 10,700 | |
| 3 years | 3,601 | 10,700 | |
| 5 years | 3,191 | 10,700 | |
| 10 years | 1,003.33 | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/01/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 28/03/2024 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 01/03/1993 |
Masayuki Oku
BRD | Director/Board Member | 81 | 01/03/2015 |
| Director/Board Member | 77 | 01/03/2017 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.13% | -2.63% | +6.96% | +113.00% | 82.07B | ||
| -0.25% | +0.31% | +36.39% | +130.32% | 911B | ||
| -0.30% | -0.48% | +49.24% | +44.31% | 554B | ||
| -0.68% | +1.82% | +14.85% | +46.30% | 378B | ||
| -0.42% | +2.53% | +24.56% | +13.82% | 333B | ||
| +0.50% | +1.34% | +33.90% | +16.15% | 288B | ||
| -0.42% | +1.49% | +27.07% | +30.97% | 287B | ||
| -1.09% | -0.40% | +44.93% | -2.16% | 282B | ||
| +0.31% | -3.61% | -36.78% | -49.84% | 198B | ||
| +0.25% | -1.45% | +20.57% | +48.41% | 179B | ||
| Average | -0.27% | +1.03% | +22.17% | +39.13% | 349.15B | |
| Weighted average by Cap. | -0.39% | +1.19% | +29.04% | +53.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,382B 8.7B 7.48B 6.85B 6.47B 11.96B 841B 12.15B 81.22B 31.78B 397B 32.66B 31.97B | 1,521B 9.58B 8.24B 7.54B 7.12B 13.17B 925B 13.38B 89.4B 34.98B 437B 35.95B 35.19B |
| Net income | 511B 3.21B 2.76B 2.53B 2.39B 4.42B 310B 4.49B 30B 11.74B 147B 12.06B 11.81B | 589B 3.71B 3.19B 2.92B 2.76B 5.1B 358B 5.18B 34.6B 13.54B 169B 13.91B 13.62B |
| Net Debt | -970B -6.11B -5.25B -4.81B -4.54B -8.4B -590B -8.53B -57.02B -22.31B -279B -22.93B -22.44B | -1,226B -7.72B -6.64B -6.08B -5.74B -10.61B -746B -10.78B -72.06B -28.2B -352B -28.98B -28.36B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/05/26 | 7,889.00 ¥ | -0.13% | 1,019,000 |
| 20/05/26 | 7,899.00 ¥ | -0.47% | 2,507,400 |
| 19/05/26 | 7,936.00 ¥ | +0.65% | 2,367,900 |
| 18/05/26 | 7,885.00 ¥ | -0.67% | 1,512,400 |
| 15/05/26 | 7,938.00 ¥ | -1.95% | 2,260,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















